89 related articles for article (PubMed ID: 27465886)
21. [Significance of prognostic evaluation of International Federation of Gynecology and Obstetrics 2009 staging system on stage I endometrioid adenocarcinoma].
Wang ZQ; Zhang Y; Wang JL; Shen DH; Mu T; Zhao X; Yao YY; Bai Y; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):33-9. PubMed ID: 22455691
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of tumor-associated macrophages in endometrial adenocarcinoma.
Kübler K; Ayub TH; Weber SK; Zivanovic O; Abramian A; Keyver-Paik MD; Mallmann MR; Kaiser C; Serçe NB; Kuhn W; Rudlowski C
Gynecol Oncol; 2014 Nov; 135(2):176-83. PubMed ID: 25173585
[TBL] [Abstract][Full Text] [Related]
23. CD8 down-regulation on cytotoxic T lymphocytes of patients with endometrioid endometrial carcinomas.
Pascual-García M; Bértolo C; Nieto JC; Serrat N; Espinosa Í; D'Angelo E; Muñoz R; Rovira R; Vidal S; Prat J
Hum Pathol; 2016 Oct; 56():180-8. PubMed ID: 27346574
[TBL] [Abstract][Full Text] [Related]
24. Loss of ASRGL1 expression is an independent biomarker for disease-specific survival in endometrioid endometrial carcinoma.
Edqvist PH; Huvila J; Forsström B; Talve L; Carpén O; Salvesen HB; Krakstad C; Grénman S; Johannesson H; Ljungqvist O; Uhlén M; Pontén F; Auranen A
Gynecol Oncol; 2015 Jun; 137(3):529-37. PubMed ID: 25858696
[TBL] [Abstract][Full Text] [Related]
25. S100 as an immunohistochemically-detected marker with prognostic significance in endometrial carcinoma.
Honig A; Schaller N; Dietl J; Backe J; Kammerer U
Anticancer Res; 2005; 25(3A):1747-53. PubMed ID: 16033094
[TBL] [Abstract][Full Text] [Related]
26. [Relationship between the expression of dual specificity phosphatase-1 and the prognosis of endometrioid adenocarcinoma].
Gao BR; Yao YY; Chen YH; Li XP; Wang JL; Wei LH
Zhonghua Yi Xue Za Zhi; 2013 Aug; 93(31):2493-5. PubMed ID: 24300273
[TBL] [Abstract][Full Text] [Related]
27. Minichromosome maintenance complex component 6 (MCM6) expression correlates with histological grade and survival in endometrioid endometrial adenocarcinoma.
Hotton J; Agopiantz M; Leroux A; Charra-Brunaud C; Marie B; Busby-Venner H; Morel O; Guéant JL; Vignaud JM; Battaglia-Hsu SF; Gauchotte G
Virchows Arch; 2018 Apr; 472(4):623-633. PubMed ID: 29243125
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of Musashi-1 in endometrioid adenocarcinoma.
Ma L; Xu YL; Ding WJ; Shao HF; Teng YC
Int J Clin Exp Pathol; 2015; 8(5):4564-72. PubMed ID: 26191146
[TBL] [Abstract][Full Text] [Related]
29. [Prognostic factors of stage III endometrial carcinoma].
Li J; Kong WM
Zhonghua Yi Xue Za Zhi; 2009 Jan; 89(3):198-200. PubMed ID: 19537039
[TBL] [Abstract][Full Text] [Related]
30. The expression ratios of estrogen receptor α (ERα) to estrogen receptor β1 (ERβ1) and ERα to ERβ2 identify poor clinical outcome in endometrioid endometrial cancer.
Zannoni GF; Monterossi G; De Stefano I; Gargini A; Salerno MG; Farulla I; Travaglia D; Vellone VG; Scambia G; Gallo D
Hum Pathol; 2013 Jun; 44(6):1047-54. PubMed ID: 23266443
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of progesterone receptor immunohistochemistry in endometrial carcinoma.
Fukuda K; Mori M; Uchiyama M; Iwai K; Iwasaka T; Sugimori H
Gynecol Oncol; 1998 Jun; 69(3):220-5. PubMed ID: 9648591
[TBL] [Abstract][Full Text] [Related]
32. Cyclin E Expression Correlates with Cancer-specific Survival in Endometrial Endometrioid Adenocarcinoma.
Santala S; Talvensaari-Mattila A; Soini Y; Santala M
Anticancer Res; 2015 Jun; 35(6):3393-7. PubMed ID: 26026100
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathological characteristics, treatment and outcomes in uterine carcinosarcoma and grade 3 endometrial cancer patients: a comparative study.
Zhu J; Wen H; Bi R; Wu X
J Gynecol Oncol; 2016 Mar; 27(2):e18. PubMed ID: 26463439
[TBL] [Abstract][Full Text] [Related]
34. Infiltration of CD3⁺ and CD68⁺ cells in bladder cancer is subtype specific and affects the outcome of patients with muscle-invasive tumors.
Sjödahl G; Lövgren K; Lauss M; Chebil G; Patschan O; Gudjonsson S; Månsson W; Fernö M; Leandersson K; Lindgren D; Liedberg F; Höglund M
Urol Oncol; 2014 Aug; 32(6):791-7. PubMed ID: 24794251
[TBL] [Abstract][Full Text] [Related]
35. Markers of proliferative activity are predictors of patient outcome for low-grade endometrioid adenocarcinoma but not papillary serous carcinoma of endometrium.
Al Kushi A; Lim P; Aquino-Parsons C; Gilks CB
Mod Pathol; 2002 Apr; 15(4):365-71. PubMed ID: 11950909
[TBL] [Abstract][Full Text] [Related]
36. The immunoexpression of p53 and Snail in endometrioid endometrial carcinomas.
Dragomirescu M; Stepan AE; Mărgăritescu C; Simionescu CE
Rom J Morphol Embryol; 2018; 59(1):131-137. PubMed ID: 29940620
[TBL] [Abstract][Full Text] [Related]
37. Cell proliferation, measured as flow cytometric S-phase fraction, is a strong prognostic indicator in FIGO stage I endometrioid endometrial carcinoma: a population-based study.
Green RW; Engblom S; Baldetorp B; Hartman L; Måsbäck A; Bjurberg M
Acta Obstet Gynecol Scand; 2015 Oct; 94(10):1064-73. PubMed ID: 26123703
[TBL] [Abstract][Full Text] [Related]
38. GLUT-1 Expression in Proliferative Endometrium, Endometrial Hyperplasia, Endometrial Adenocarcinoma and the Relationship Between GLUT-1 Expression and Prognostic Parameters in Endometrial Adenocarcinoma.
Canpolat T; Ersöz C; Uğuz A; Vardar MA; Altintaş A
Turk Patoloji Derg; 2016; 32(3):141-7. PubMed ID: 27562387
[TBL] [Abstract][Full Text] [Related]
39. Serous versus high-grade endometrioid endometrial carcinoma: immunohistochemistry of RFP is not useful for differentiation.
Ussakli C; Usubutun A; Dincer N; Dolgun A; Bülbül D; Isikdogan Z; Haberal N; Ozen O; Tezel GG
Pol J Pathol; 2016; 67(3):221-227. PubMed ID: 28155970
[TBL] [Abstract][Full Text] [Related]
40. Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer.
Amant F; Cadron I; Fuso L; Berteloot P; de Jonge E; Jacomen G; Van Robaeys J; Neven P; Moerman P; Vergote I
Gynecol Oncol; 2005 Aug; 98(2):274-80. PubMed ID: 15972232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
